LH and FSH After PCT: What Your Gonadotropin Results Actually Mean for Recovery
LH and FSH after PCT are the two markers that tell you whether your hormonal recovery is actually happening, yet they are the markers that most UK steroid users either do not test at all or misinterpret when they do. The conversation about post-cycle recovery almost always focuses on total testosterone as the measure of success. That focus is misplaced. Total testosterone is a lagging indicator. It is the last thing to normalise in the recovery sequence, not the first. LH and FSH are the leading indicators. They rise before testosterone rises, and their behaviour in the weeks after PCT tells you whether the system driving testosterone production has restarted before the output number catches up. Understanding what LH and FSH are, why they fall to zero on cycle, how SERMs raise them during PCT, what different post-PCT patterns mean and when to act on each one is the difference between managing recovery accurately and making blind adjustments to a process you cannot actually see. All PCT compounds referenced throughout this guide are available from the Intex Pharma shop with same day UK despatch.
Available now at Intex Pharma UK
Complete PCT stack — Nolvadex, Clomid and HCG in stock
Everything you need for a complete post-cycle protocol. Janoshik verified every batch. Same day UK despatch. Ships worldwide. 15% off with Bitcoin using code INTEXBTC15. First order 20% off over £200 with code WELCOME20.
The HPG axis: understanding the system before understanding the markers
To interpret LH and FSH results correctly, you need to understand precisely what they represent within the hormonal signalling chain that controls testosterone production. The hypothalamic-pituitary-gonadal axis operates as a three-tier cascade. Each tier depends on the tier above it, and disruption at any level produces a specific and diagnostically distinct pattern in the bloodwork.
The hypothalamus releases gonadotropin-releasing hormone (GnRH) in timed pulses — typically one pulse every 60 to 120 minutes under normal physiological conditions. These pulses are critical. GnRH delivered continuously, rather than in pulses, actually suppresses the pituitary rather than stimulating it, which is why GnRH analogues used in some medical contexts have a suppressive rather than stimulating effect. The pulse frequency is regulated by feedback signals from testosterone and oestradiol in the bloodstream. High circulating androgens and oestrogens reduce GnRH pulse frequency. Low circulating androgens and oestrogens increase it.
GnRH pulses from the hypothalamus stimulate gonadotroph cells in the anterior pituitary to release LH and FSH. LH then travels through the bloodstream to the Leydig cells in the testes and signals them to produce testosterone. FSH signals Sertoli cells to support spermatogenesis. The testes produce testosterone, which rises in the bloodstream, feeds back to the hypothalamus and pituitary and reduces GnRH, LH and FSH output, completing the feedback loop that keeps testosterone within the physiological range under natural conditions.
When you introduce exogenous testosterone through a steroid cycle, the hypothalamus detects supraphysiological androgen levels and reduces GnRH pulse frequency to near zero. The pituitary, receiving no GnRH signal, stops producing LH and FSH. The testes, receiving no LH signal, stop producing testosterone. This suppression is complete in most users within two to four weeks of starting a cycle and is universal across all anabolic steroid compounds without exception. The only variation is the degree and duration of suppression, which depends on the compound potency, dose and cycle length.
Why LH and FSH fall to undetectable levels on cycle
During a cycle, LH and FSH will typically read as less than 0.1 to 0.5 IU/L on standard UK laboratory assays, effectively undetectable. This is not a sign of a problem with your pituitary or hypothalamus. It is the expected and mechanistically inevitable response to exogenous androgen-mediated suppression of GnRH pulse frequency. No SERM, HCG or any other intervention will restore LH and FSH to normal levels while supraphysiological androgens are still present in the bloodstream, which is precisely why timing PCT correctly relative to ester clearance is so critical.
The clearance period required before starting PCT depends on the longest-acting ester in the cycle. For Testosterone Enanthate with an eight-day half-life, the standard recommendation is two weeks after the last injection before starting SERMs. For Testosterone Cypionate with a ten-day half-life, two weeks is also appropriate. For cycles containing Testosterone Decanoate as in Intex Pharma T400, the Decanoate component has a 14 to 16-day half-life and requires three weeks of clearance time before PCT begins. Starting SERMs while the long-acting ester is still actively suppressing the HPG axis renders the SERM phase ineffective. LH and FSH cannot rise while the hypothalamus is still detecting supraphysiological androgens in the bloodstream.
How SERMs drive LH and FSH recovery after PCT
Intex Pharma Nolvadex and Intex Pharma Clomid work through different but complementary mechanisms to drive the recovery of LH and FSH.
Tamoxifen (Nolvadex) is a pure oestrogen receptor antagonist at the hypothalamus and pituitary. By blocking oestrogen receptors at these sites, it removes the oestrogenic component of the negative feedback that was suppressing GnRH pulse frequency. The hypothalamus interprets the blocked receptors as a low-oestrogen environment and responds by increasing GnRH pulse frequency. Rising GnRH drives increasing LH and FSH output from the pituitary within five to seven days of starting. Shabsigh et al., published in the International Journal of Impotence Research, confirmed that Tamoxifen increases pituitary gonadotropins and testicular testosterone, facilitating hormonal normalisation post-anabolic steroid use.
Clomiphene citrate (Clomid) has a more complex mechanism. It is a partial oestrogen receptor agonist at the hypothalamus but a pure antagonist at the pituitary. This dual action produces a stronger gonadotropin stimulus than Tamoxifen in some users, but its partial agonism at the hypothalamus can also produce mood and visual side effects that Tamoxifen does not. Clinical PCT protocols confirm that LH and FSH begin rising within five to seven days of starting Clomid at standard doses. The gonadotropin stimulus from Clomid is generally considered stronger than Tamoxifen at equivalent clinical doses, which is why Clomid is favoured for recovery after heavily suppressive cycles.
It is important to understand what SERMs do not do. They do not directly stimulate the testes. They do not tell the Leydig cells to produce testosterone. They restore the hypothalamic-pituitary signalling conditions that allow the testes to receive the LH signal they need to restart. The recovery sequence is therefore: SERM starts, oestrogen receptor blockade established over seven to ten days, GnRH frequency rises, LH and FSH rise over two to three weeks, testes respond to rising LH and begin producing testosterone over three to six weeks. Total testosterone is the last thing to change, not the first, which is precisely why using total testosterone alone as the measure of PCT success produces both false positives and false negatives.
The complete recovery timeline: what the research shows
Understanding the clinical timeline of HPG axis recovery prevents misinterpretation of bloodwork results at every stage of PCT and beyond.
A prospective observational study published in Problems of Endocrinology followed 44 male AAS users with a median cycle duration of six months. During AAS use, LH was 0.2 mIU/mL in 84 percent of participants. Three months after cessation with PCT, LH had recovered to 4.12 mIU/mL in the majority, though testosterone below 3.4 ng/mL persisted in 20.5 percent of participants at this timepoint. A clear correlation was established between the duration of AAS use and the recovery trajectory — longer cycles predicted slower recovery.
A scoping review published in ScienceDirect examining physical, psychological and biochemical recovery from anabolic steroid-induced hypogonadism found that near-complete recovery of testosterone is expected over months, and complete gonadotropin recovery is expected over three to six months. The review specifically noted that recovery is immensely variable in duration and degree and that the paucity of prospective controlled data makes it difficult to provide precise timelines for individual users.
A comparative outcomes study published in PubMed confirmed that spontaneous hormonal recovery occurs within six to twelve months after AAS cessation, and that PCT facilitates earlier hormonal normalisation compared to no intervention. The addition of HCG to clomiphene citrate was associated with superior recovery of semen parameters and testicular volume compared to clomiphene alone, supporting the combined protocol approach.
The clinical picture that emerges from this research is one of highly variable but generally favourable outcomes when PCT is properly timed and completed. Most users with standard cycle durations and no pre-existing hormonal issues achieve full LH and FSH recovery within three months and full testosterone recovery within six to twelve months. The minority who do not recover fully within this window are disproportionately those with long cumulative cycle histories, very heavy suppressive cycles, or pre-existing HPG axis vulnerabilities.
How to read your post-PCT LH and FSH results: every pattern explained
The following patterns represent the four most commonly encountered post-PCT bloodwork results and what each one actually means for management. In each case, the bloodwork is assumed to have been taken four weeks after the last SERM tablet, which is the correct timing for an accurate autonomous HPG axis assessment.
The pattern most users misread: rising LH and FSH with still-low testosterone
Of all the post-PCT bloodwork patterns, the combination of rising LH and FSH alongside still-low total testosterone is the one most frequently interpreted as evidence that PCT has failed. It has not failed. It is working.
Rising LH and FSH four weeks after completing PCT means the HPG axis has restarted at the hypothalamic and pituitary level. The brain is signalling correctly. The problem is that the testes have not yet responded fully to the restored LH signal. Leydig cells, after months of receiving no LH stimulus, take time to upregulate their steroidogenic capacity. This lag between the gonadotropin signal recovering and the testosterone output catching up is physiologically normal and well-documented in the clinical recovery literature.
The appropriate intervention for this specific pattern is Intex Pharma HCG 5000IU at 500IU every other day for two weeks. HCG mimics LH at the testicular receptor, bypassing the pituitary entirely and directly stimulating Leydig cell steroidogenesis. It addresses testicular responsiveness lag specifically — the precise limitation that is holding back testosterone recovery in this pattern. Data from Fertility and Sterility on HCG treatment in testosterone-induced infertility showed that at three months of HCG treatment, 71.4 percent of patients still demonstrated pituitary suppression, confirming that even extended HCG use in more severe suppression cases produces meaningful testicular stimulation before the pituitary fully recovers. For standard post-cycle recovery, a two-week HCG course at this stage typically produces meaningful testosterone elevation within one to two weeks as the Leydig cells respond to the direct LH-mimetic stimulus.
Extending the SERM course in response to this pattern is the wrong intervention because the axis signalling is already working. Adding more SERM to a system whose pituitary is already producing adequate LH and FSH adds no additional stimulus. It is the testicular end of the axis that needs addressing, and HCG is the only compound that does this directly.
What flat LH and FSH four weeks after PCT means
LH and FSH that remain suppressed or near-suppressed four weeks after the last SERM tablet indicate that the HPG axis has not yet achieved autonomous function. This is a more significant finding than low testosterone with rising gonadotropins, because it points to a problem at the hypothalamic or pituitary level rather than the testicular level.
The most common causes are: starting PCT before the longest-acting ester had fully cleared, meaning the SERM was competing against ongoing androgen-mediated suppression throughout the entire course; running a 19-nor compound (Nandrolone or Trenbolone) without Cabergoline during PCT, leaving prolactin-mediated suppression of GnRH active through a pathway that SERMs cannot address; or running a very long or heavily multi-compound cycle that has suppressed the axis beyond what a standard four-week PCT course can fully reverse.
The first step when facing this pattern is to review timing. If you started PCT at two weeks after the last injection of a Decanoate-containing blend and your LH and FSH are still flat, the most likely explanation is that Decanoate was still active during most of the SERM phase. Run bloodwork to check whether testosterone is still measurably elevated from the residual ester before concluding the axis has failed to restart. The second step is to check prolactin if the cycle included any 19-nor compound. Elevated prolactin independently suppresses GnRH at the hypothalamus through a dopaminergic mechanism that SERMs cannot target. Intex Pharma Cabergoline at 0.25mg twice weekly alongside an extended SERM course is the appropriate approach when prolactin elevation is confirmed post-cycle.
When to run post-PCT bloodwork for the most accurate results
Timing the post-PCT blood test correctly is as important as knowing what to measure. Testing too early produces misleading results that do not reflect autonomous HPG function.
Tamoxifen has a half-life of five to seven days and an active metabolite (endoxifen) with a half-life of up to fourteen days. Running bloodwork in the week after the last Nolvadex tablet means the drug is still circulating and still producing oestrogen receptor blockade at the pituitary. LH and FSH at this point are being pharmacologically supported, not autonomously maintained. A result that looks normal immediately post-PCT may fall significantly over the following two weeks as the drug clears, revealing an axis that has not yet achieved independent function.
Clomiphene and its active isomer enclomiphene have half-lives of five to seven days and fourteen days respectively. The same principle applies. Four weeks after the last SERM tablet is the minimum interval for a reliable autonomous HPG function assessment. At this point, the drug has cleared, any residual pharmacological support of gonadotropin output has resolved, and the LH, FSH and testosterone values you measure reflect what the recovered axis is capable of producing on its own.
The complete post-PCT panel should include total testosterone, free testosterone, LH, FSH, oestradiol (sensitive LC-MS/MS assay), SHBG and prolactin (if the cycle included any 19-nor compound). Run fasted in the morning for the most consistent reference values. All compounds needed for a complete PCT protocol are available at the Intex Pharma shop.
The prolactin dimension: why 19-nor users have a different recovery challenge
Users who ran Nandrolone or Trenbolone face a post-cycle recovery challenge that SERM-only PCT is structurally unable to address. These 19-nor compounds elevate prolactin through progestogenic receptor activation at the pituitary. Prolactin suppresses GnRH output from the hypothalamus through a mechanism entirely separate from the oestrogen feedback pathway that SERMs target.
Running Nolvadex or Clomid after a Nandrolone or Trenbolone cycle addresses the oestrogen component of HPG axis suppression but leaves the prolactin-mediated GnRH suppression fully active. The result is an HPG axis that cannot restart autonomously not because the SERM is failing but because a second suppressive mechanism remains unaddressed. LH and FSH will not rise normally in this scenario regardless of SERM dose or duration.
The solution is to run Cabergoline at 0.25mg twice weekly from the start of PCT until bloodwork four weeks after completing the full protocol confirms prolactin has returned to the reference range. Confirm prolactin normalisation before stopping Cabergoline. Do not assume the 19-nor compound has cleared and prolactin has self-resolved. For Nandrolone Decanoate with a 15-day half-life, measurable compound can persist for six to eight weeks after the last injection, continuing to drive prolactin elevation throughout the early PCT period.
Frequently asked questions
What should LH and FSH be after PCT?
Four weeks after the last SERM tablet, LH should be within the male reference range of approximately 1.7 to 8.6 IU/L and FSH within approximately 1.5 to 12.4 IU/L on most UK laboratory panels, though ranges vary slightly between laboratories. Values within these ranges four weeks post-PCT confirm the HPG axis is producing adequate gonadotropin output autonomously rather than under pharmacological support. Values below these ranges at this timepoint indicate the axis has not yet achieved autonomous function and further investigation or extended therapy is warranted.
Why are LH and FSH rising but testosterone is still low after PCT?
Rising LH and FSH with still-low testosterone indicates testicular responsiveness lag rather than an axis failure. The hypothalamic-pituitary signalling chain has restarted correctly, but the Leydig cells have not yet upregulated steroidogenic capacity in response to the restored LH signal. This is normal in the recovery sequence and typically responds well to HCG at 500IU every other day for two weeks, which directly stimulates Leydig cell testosterone production by mimicking LH at the testicular receptor, bypassing the pituitary entirely.
When is the best time to run bloodwork after PCT?
Four weeks after the last SERM tablet. Testing earlier, while Nolvadex or Clomid is still circulating or clearing, gives a pharmacologically supported picture of gonadotropin levels rather than autonomous HPG function. Tamoxifen has a five to seven-day half-life and an active metabolite with a fourteen-day half-life. At four weeks post-PCT, the drug has fully cleared and the result reflects genuine autonomous axis function rather than residual drug effect.
What does it mean if LH and FSH are still suppressed after completing PCT?
Flat or suppressed LH and FSH four weeks after the last SERM tablet indicates the HPG axis has not yet restarted autonomously. The most common causes are: starting PCT too early before the longest-acting ester had adequately cleared; elevated prolactin from a 19-nor compound suppressing GnRH through a pathway SERMs cannot address; or a heavily suppressive cycle requiring a longer recovery period than a standard four-week course provides. Check prolactin if any 19-nor compound was used. Review the timing of PCT initiation relative to ester half-lives. An extended SERM course of two to four additional weeks is the appropriate first step before considering clinical evaluation.
How long does full hormonal recovery take after a steroid cycle?
A prospective study published in Problems of Endocrinology following 44 AAS users found that LH recovered to normal range in 95.5 percent of participants within three months of cessation with PCT, while testosterone below the recovery threshold persisted in 20.5 percent at three months. A ScienceDirect scoping review found that near-complete testosterone recovery is expected over months with complete gonadotropin recovery expected over three to six months. A 2019 cross-sectional study in the Journal of Clinical Endocrinology and Metabolism found that 43 percent of men who had stopped AAS for a median of 32 months still had testosterone below 300 ng/dL without PCT. The combined picture is that properly timed PCT substantially accelerates recovery, most users achieve full LH and FSH recovery within three months, and testosterone typically follows over six to twelve months, with a minority requiring longer depending on cumulative cycle history.
Should I run HCG before PCT or during PCT?
HCG is most effective when run before SERMs begin, not during the SERM phase. HCG mimics LH and directly stimulates testicular testosterone production. During the SERM phase, HCG-generated testosterone can suppress the HPG axis through the same feedback mechanism the SERMs are trying to overcome, partially counteracting the gonadotropin stimulus the SERM is producing. The optimal protocol for users who did not run HCG during the cycle is to run HCG at 500IU every other day for two weeks after the ester has cleared, then begin the SERM course once the HCG is stopped. This sequence primes the testes before the SERM restores the hypothalamic-pituitary signalling. The exception is the specific post-PCT pattern of rising LH and FSH with still-low testosterone, where adding HCG after PCT has completed addresses testicular lag without interfering with the axis recovery already in progress.
Related guides from Intex Pharma
- Why testosterone is still low after PCT and what Nolvadex does about it
- Nolvadex or Clomid first for PCT — the sequencing question answered
- Testicular atrophy on a steroid cycle and whether HCG can reverse it
- HCG monotherapy as a TRT alternative in the UK
- Bloodwork before your first steroid cycle — the complete UK panel
- High prolactin on a steroid cycle — symptoms and how Cabergoline fixes it